Potential value of miR-221/222 as diagnostic, prognostic, and therapeutic biomarkers for diseases

137Citations
Citations of this article
118Readers
Mendeley users who have this article in their library.

Abstract

microRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by base pairing with their target messenger RNAs. Dysregulation of miRNAs is involved in the pathological initiation and progression of many human diseases. miR-221 and miR-222 (miR-221/222) are two highly homologous miRNAs, and they are significantly overexpressed in several types of human diseases. Silencing miR-221/222 could represent a promising approach for therapeutic studies. In the present review, we will describe the potential value of miR-221/222 as diagnostic, prognostic, and therapeutic biomarkers in various diseases including cancer and inflammatory diseases.

Cite

CITATION STYLE

APA

Song, J., Ouyang, Y., Che, J., Li, X., Zhao, Y., Yang, K., … Yuan, W. (2017, February 16). Potential value of miR-221/222 as diagnostic, prognostic, and therapeutic biomarkers for diseases. Frontiers in Immunology. Frontiers Research Foundation. https://doi.org/10.3389/fimmu.2017.00056

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free